MEDICO
Medico Remedies Limited (MEDICO) Stock Analysis
Medico Remedies Limited is an Indian pharmaceutical company producing generic formulations for domestic distribution through wholesalers and retailers. It operates manufacturing plants with a broad SKU base in acute therapies. Competition and price control affect margins. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹22.80
+4.30% 1W | -55.70% 52W
Market Cap
189 CR
P/E Ratio
13.7
52W High
₹56.9
52W Low
₹20.5
Div. Yield
0%
Beta
0.7
50 DMA
₹38.6
200 DMA
₹42.2
Profit Margin
5.8%
Inst. Own.
0%
📊 ANALYZING TREND
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31.47 | 42.36 | 29.77 | 41.32 | 30.80 | 39.35 | 39.49 | 41.30 | 38.25 | 52.64 | 58.68 | 56.81 | 69.40 |
| Expenses | 29.01 | 39.29 | 27.04 | 36.67 | 27.98 | 36.94 | 36.38 | 34.64 | 35.43 | 49.91 | 54.35 | 49.66 | 66.10 |
| Operating Profit | 2.46 | 3.07 | 2.73 | 4.65 | 2.82 | 2.41 | 3.11 | 6.66 | 2.82 | 2.73 | 4.33 | 7.15 | 3.30 |
| OPM % | 7.82% | 7.25% | 9.17% | 11.25% | 9.16% | 6.12% | 7.88% | 16.13% | 7.37% | 5.19% | 7.38% | 12.59% | 4.76% |
| Other Income | 0.31 | 0.96 | 0.27 | 0.58 | 0.29 | 0.68 | 1.43 | 0.29 | 0.66 | 1.72 | 0.68 | 2.87 | 1.17 |
| Interest | 0.17 | 0.18 | 0.22 | 0.25 | 0.18 | 0.21 | 0.28 | 0.49 | 0.28 | 0.24 | 0.39 | 0.90 | 0.41 |
| Depreciation | 0.71 | 0.71 | 0.72 | 0.74 | 0.75 | 0.75 | 0.76 | 0.77 | 0.77 | 0.73 | 0.79 | 0.80 | 0.72 |
| Profit before tax | 1.89 | 3.14 | 2.06 | 4.24 | 2.18 | 2.13 | 3.50 | 5.69 | 2.43 | 3.48 | 3.83 | 8.32 | 3.34 |
| Tax % | 29.63% | 22.61% | 30.10% | 26.89% | 27.06% | 27.23% | 25.14% | 23.90% | 25.51% | 25.86% | 25.07% | 29.69% | 24.55% |
| Net Profit | 1.32 | 2.43 | 1.45 | 3.10 | 1.58 | 1.55 | 2.62 | 4.34 | 1.82 | 2.57 | 2.87 | 5.86 | 2.52 |
| EPS in Rs | 0.16 | 0.29 | 0.17 | 0.37 | 0.19 | 0.19 | 0.32 | 0.52 | 0.22 | 0.31 | 0.35 | 0.71 | 0.30 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51 | 67 | 54 | 61 | 98 | 89 | 122 | 121 | 140 | 145 | 151 | 206 | 238 |
| Expenses | 48 | 63 | 50 | 58 | 95 | 86 | 117 | 114 | 131 | 132 | 136 | 189 | 220 |
| Operating Profit | 3 | 4 | 4 | 3 | 3 | 3 | 5 | 7 | 10 | 13 | 15 | 17 | 18 |
| OPM % | 6% | 5% | 7% | 6% | 2.8% | 3.2% | 4.3% | 6% | 7% | 9% | 10% | 8% | 7% |
| Other Income | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 2 | 4 | 2 | 3 | 6 | 6 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 1 | 2 | 2 | 2 | 2 | 2 | 4 | 6 | 10 | 11 | 14 | 18 | 19 |
| Tax % | 28% | 40% | 4% | 35% | 28% | 26% | 30% | 26% | 28% | 27% | 25% | 27% | |
| Net Profit | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 5 | 7 | 8 | 10 | 13 | 14 |
| EPS in Rs | 0.25 | 0.35 | 0.25 | 0.15 | 0.19 | 0.20 | 0.31 | 0.58 | 0.87 | 1.00 | 1.22 | 1.58 | 1.67 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 14.0% | 11.0% | 12.0% |
| Profit CAGR | 22.0% | 38.0% | 28.0% |
Shareholding Pattern
Promoters62.59%
FIIs0.07%
DIIs0.01%
Public37.33%
Promoters61.38%
FIIs0.30%
DIIs0.01%
Public38.30%
Promoters61.38%
FIIs0.49%
Public38.13%
Promoters61.38%
FIIs0.03%
Public38.60%
Promoters61.38%
FIIs0.08%
Public38.55%
Promoters73.34%
FIIs0.53%
Public26.15%
Promoters73.34%
FIIs0.29%
DIIs0.74%
Public25.63%
Promoters63.79%
FIIs0.11%
DIIs0.01%
Public36.08%
Promoters61.38%
FIIs0.03%
Public38.60%
Promoters61.38%
FIIs0.08%
Public38.55%
MEDICO
Holdings Analysis
Key strengths & risk signals
55
Overall
76
Fundamental
35
Technical
Risks (4)
LOW MARGIN! 5.8% profit margin - thin profits.
POOR YEAR! Stock declined 55.7% in the last year.
BEARISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 337,783 vs down days: 869,899. Ratio: 0.39x
WEAK POSITION! Current price (22.8) is below both moving averages.
Strengths (3)
UNDERVALUED! PEG of 0.63 indicates stock is cheap relative to growth.
OVERSOLD! RSI at 24.7 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
Fundamental & Technical Analysis
55Overall
76Fundamental
35Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 13.8% (GOOD, 11/15). Profit CAGR: 21.9% (EXCELLENT, 15/15).
Profit Margin
3/10
LOW MARGIN! 5.8% profit margin - thin profits.
PEG Valuation
10/10
UNDERVALUED! PEG of 0.63 indicates stock is cheap relative to growth.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 25.46% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (38.6) is below 200-day average (42.2) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (22.8) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
0/10
POOR YEAR! Stock declined 55.7% in the last year.
Volume Sentiment
5/30
BEARISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 337,783 vs down days: 869,899. Ratio: 0.39x
RSI
5/5
OVERSOLD! RSI at 24.7 - potential bounce opportunity.
52W Range
1/5
WEAK! Trading at 6.3% of 52W range - near yearly lows.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - 4.3% (1 week), -35.7% (1 month), -42.6% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDICO | ₹22.80 | 13.7 | 5.8% | 13.8% | 21.9% | -55.7% | 55 | BREAKDOWN | +38.9% | -57.6% | +81.2% | +22.2% |
| NECLIFE | ₹10.10 | 28.9 | – | – | – | -24.9% | 46 | BREAKDOWN | -75.6% | -77.3% | – | – |
| BROOKS | ₹70.10 | 15.6 | 15.9% | 11.0% | – | -52.9% | 62 | BREAKOUT | -118.8% | -220.0% | -9.8% | +13.9% |
| NATCAPSUQ | ₹160.00 | – | -8.1% | 3.6% | – | -32.4% | 46 | BREAKDOWN | +1.8% | +14.0% | +7.7% | -16.8% |
| BALPHARMA | ₹93.10 | 20.5 | 2.2% | 0.1% | 34.7% | +18.7% | 66 | CONSOLIDATING UP | +450.0% | -69.4% | +34.4% | +5.4% |
| PAR | ₹117.10 | 11 | 13.3% | 11.0% | 1.0% | +21.6% | 66 | BREAKDOWN | +42.7% | +423.3% | +20.3% | +59.6% |
| BALAXI | ₹22.30 | 49.6 | 0.5% | -7.1% | -68.6% | -48.5% | 51 | APPROACHING SUPPORT | +333.3% | +116.7% | +14.1% | +14.1% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -16.8% | 47 | BREAKDOWN | -52.8% | +8.7% | +27.3% | +2.9% |
Data from TradeAlone · Updated daily
No news tagged for MEDICO yet.
